-
EP2124920
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2124920
| EP2124920 - ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATNG CHRONIC PAIN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.11.2016 Database last updated on 29.10.2024 | Most recent event Tooltip | 04.11.2016 | Application deemed to be withdrawn | published on 07.12.2016 [2016/49] | Applicant(s) | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | [N/P] |
| Former [2009/49] | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine CA 92612 / US | ||
| Former [2008/36] | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | Inventor(s) | 01 /
GIL, Daniel W. 2541 Point Del Mar Corona Del Mar, CA 92625 / US | 02 /
DONELLO, John E. 34041 Pequito Drive Dana Point, CA 92629 / US | [2009/49] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2009/49] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 07855143.9 | 13.12.2007 | [2009/49] | WO2007US87455 | Priority number, date | US20060871716P | 22.12.2006 Original published format: US 871716 P | [2009/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008079720 | Date: | 03.07.2008 | Language: | EN | [2008/27] | Type: | A1 Application with search report | No.: | EP2124920 | Date: | 02.12.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application. | [2009/49] | Search report(s) | International search report - published on: | EP | 03.07.2008 | Classification | IPC: | A61K31/195, A61K31/197, A61K31/4164, A61K31/4174, A61K31/4178, A61K45/00, A61K31/4709, A61P29/00, A61P29/02 | [2009/49] | CPC: |
A61K45/06 (EP,US);
A61K31/195 (EP,US);
A61K31/197 (EP,US);
A61K31/4164 (EP,US);
A61K31/4174 (EP,US);
A61K31/4709 (EP,US);
A61P25/00 (EP);
A61P25/04 (EP);
A61P29/00 (EP);
A61P29/02 (EP)
(-)
| C-Set: |
A61K31/195, A61K2300/00 (EP,US);
A61K31/197, A61K2300/00 (US,EP);
A61K31/4164, A61K2300/00 (US,EP);
A61K31/4174, A61K2300/00 (US,EP); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/49] | Title | German: | ALPHA-2B-REZEPTOR-AGONIST UND ANTIKONVULSIVE ZUSAMMENSETZUNG ZUR BEHANDLUNG CHRONISCHER SCHMERZEN | [2009/49] | English: | ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATNG CHRONIC PAIN | [2009/49] | French: | COMPOSITIONS D'AGONISTE DU RÉCEPTEUR ALPHA-2B ET D'ANTI-CONVULSIVANT POUR LE TRAITEMENT DE LA DOULEUR CHRONIQUE | [2009/49] | Entry into regional phase | 21.07.2009 | National basic fee paid | 21.07.2009 | Designation fee(s) paid | 21.07.2009 | Examination fee paid | Examination procedure | 21.07.2009 | Amendment by applicant (claims and/or description) | 21.07.2009 | Examination requested [2009/49] | 20.03.2012 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2012 | Reply to a communication from the examining division | 22.01.2014 | Despatch of a communication from the examining division (Time limit: M04) | 19.05.2014 | Reply to a communication from the examining division | 01.07.2016 | Application deemed to be withdrawn, date of legal effect [2016/49] | 01.08.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2016/49] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.03.2012 | Fees paid | Renewal fee | 28.12.2009 | Renewal fee patent year 03 | 27.12.2010 | Renewal fee patent year 04 | 27.12.2011 | Renewal fee patent year 05 | 26.12.2012 | Renewal fee patent year 06 | 27.12.2013 | Renewal fee patent year 07 | 29.12.2014 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.12.2015 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03099289 (ALLERGAN INC [US], et al) [X] 1-30 * page 6, line 25 - page 7, line 23 * * page 11, line 14 - page 12, line 34 * * page 21; table 1; compounds 3,11 * * page 30, line 23 - page 31, line 11 * * page 36, line 7 - page 37, line 6 * * page 39, line 20 - page 41, line 12 * * page 44, lines 3-35 * * page 50, lines 12-25 * * page 74, line 4 - page 75, line 10 * * page 80, lines 1-15 * * page 86, line 9 - page 91, line 5 *; | [A]WO02076950 (ALLERGAN INC [US]) [A] 1-30 * page 2, line 11 - page 4, line 6 * * page 6, lines 16-28 * * page 41; example I * * page 90; examples B-3b,J-2 * * page 91; examples J-3 * * page 92; example I * * page 108; example 1H * * tables 2,3; compounds B-3B, J-2, J-3 * * page 118 - page 120; example CC *; | [A]WO2006036497 (ALLERGAN INC [US], et al) [A] 1-30 * paragraphs [0003] , [0024] , [0199] - [0207] - [0221] - [0235] * * page 14; table 1; compound 7 *; | [A]US2005059721 (CHOW KEN [US], et al) [A] 1-30 * the whole document * |